The US BIOSECURE Act may prompt pharma companies to diversify their supply chain away from China, creating more opportunities for ex-China suppliers
Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · page 4 of 13
Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors · slide 4
Consulting deck · key_takeaways · summarize · overcrowded density
Slide locked Sign in to view
Slide schematic 8/8
list 3/3 paragraph 3/3 source-note 1/1 title 1/1
Components 8
bullet bullet bullet paragraph paragraph paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 1
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.